Can a smartwatch track how cancer treatment affects daily life?
NCT ID NCT07711080
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study explores whether cancer patients undergoing treatment can use a smartwatch and smartphone surveys to report their quality of life and physical activity. Over 12 weeks, participants wear a smartwatch at least 10 hours a day and complete questionnaires at several time points. The goal is to see if this approach is practical and acceptable for patients, which could pave the way for better remote monitoring in future cancer trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this approach could make it easier for doctors to monitor how cancer treatment affects patients' daily lives and physical function in real time.
- What could go wrong
- This is a small feasibility study, so it may not prove that the method works for all patients or that it improves outcomes. Technical issues or low patient compliance could limit the findings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 137 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult cancer patients prior to the start of a new treatment without restrictions related to gender, cancer site or cancer stage.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of cancer * Age≥18 * Starting a first or new anticancer treatment within one month following enrolment * Literacy in the target language * Ability to understand and fill out questionnaires * Ability to operate a smartphone * In possession of a smartphone allowing for an internet connection and willing to use this device to submit data * Written informed consent * Life expectancy\>3 months Exclusion Criteria: * Exclusively receiving palliative care * Start of cancer-related treatment \< 1 week from time of screening * Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be assessed and discussed with the patient before enrolment in this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diagnosis of cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.